Search Results 991-1000 of 17115 for monoclonal antibody

1. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

   Known severe allergic reactions to TCZ or other monoclonal antibodies;; Active TB infection;; Suspected active bacterial, fungal, viral, or other infection ...

2. A Study to Evaluate Effectiveness and Quality of Life Outcomes of Daratumumab in Relapsed/Refractory Multiple Myeloma Patients - Mayo Clinic

   Patients with history of prior daratumumab or another anti-CD38 monoclonal antibody treatment who were not refractory or intolerant to such therapy will be able ...

3. Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors - Mayo Clinic

   Monoclonal antibodies =< 3 half-lives prior to registration; Radiation therapy. Last fraction of craniospinal irradiation or total body irradiation =< 3 ...

4. Clinical Trials - Loncastuximab Tesirine in WM

   the Second International Workshop on Waldenström macroglobulinemia. - At least 2 prior lines of treatment, including an anti-CD20 monoclonal antibody-containing ...

5. A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1) - Mayo Clinic

   ... antibody or with anti-CTLA4 antibody in adult participants with advanced (unresectable or metastatic) cutaneous melanoma. Participation eligibility.

6. Role of Immunity in Efficacy of Chemotherapy Plus Trastuzumab - Mayo Clinic

   The purpose of this study is to evaluate T cell and antibody immunity in patients with HER2+ breast cancer who will receive trastuzumab with standard ...

7. Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer - Mayo Clinic

   ... monoclonal antibodies, other investigational agent) < 28 days prior to the first dose of study drug. Current or prior use of immunosuppressive medication ...

8. A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS - Mayo Clinic

   Previous Treatment with a B-cell depleting antibody; History of severe allergic reactions to humanized or murine monoclonal antibodies; Treatment with any ...

9. Efficacy and Safety of COVID-19 Vaccine in Cancer Patients - Mayo Clinic

   Aims, purpose, or objectives: To determine the antibody response to COVID-19 vaccine after vaccination. To assess the adverse events of COVID-19 vaccines in ...

10. A Study to Evaluate the Safety and Effectiveness of TEPEZZA® in Treating Patients with Chronic (Inactive) Thyroid Eye Disease - Mayo Clinic

    Treatment with any monoclonal antibody within 3 months prior to Screening. Identified pre-existing ophthalmic disease that, in the judgment of the ...